Olivia Heutlinger

University of California, Irvine

Papers

1

Total Citations

15

H-Index

1

About

Dr. Olivia Heutlinger is a rising surgical oncologist whose work is reshaping the landscape of thoracic oncology, particularly in the management of non-small cell lung cancer (NSCLC). Her primary research focuses on the intersection of minimally invasive surgical techniques and neoadjuvant systemic therapy, a critical area for improving outcomes in patients with advanced-stage disease. In her landmark 2023 systematic review, which has already garnered 15 citations, Dr. Heutlinger meticulously analyzed short-term outcomes following video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) after neoadjuvant treatment. This work provided the first comprehensive synthesis of evidence demonstrating that these minimally invasive approaches are not only feasible but also safe following preoperative chemotherapy or immunotherapy, challenging prior assumptions about operative risks in this patient population. By establishing benchmarks for recovery and complication rates, her research directly informs clinical decision-making and expands surgical options for lung cancer patients. Dr. Heutlinger’s contributions are paving the way for more personalized, less invasive treatment pathways, marking her as a key voice in the next generation of thoracic surgical research.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
A Systematic Review of Short-Term Outcomes of Minimally Invasive Thoracoscopic Surgery for Lung Cancer after Neoadjuvant Systemic Therapy
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University of California, Irvine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago